Ponsegromab Crashes Out in Frailer Heart Failure Patients

By News Health
3 hours Ago

(MedPage Today) — MINNEAPOLIS — Disappointingly, a growth differentiation factor 15 (GDF-15) neutralizer not only failed to improve functional outcomes in heart failure (HF) but was associated with harm in a trial that was terminated early…

Source link : https://www.medpagetoday.com/meetingcoverage/hfsa/117753

Author :

Publish date : 2025-10-02 16:11:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

What Constitutes 'Cure' in Colon Cancer? Researchers Propose a New Definition

Self-Blame and Panic Has Set in Among Our Pregnant Patients

AI Delphi-2M Predicts 1000+ Disease Risks — Benefits & Risk

'I have Tourette's - just treat us the same as everyone else'

Looming Health Insurance Spikes for Millions Are at the Heart of Federal Shutdown

Bariatric Surgeon Sues Hospital; $71M Jury Award in Stroke Case; Brain Tumor Lawsuit